(Q35153729)

6 August 2017

1 reference

title

Molecular design and biological activities of protein-tyrosine phosphatase inhibitors (English)

1 reference

6 August 2017

0 references

0 references

Kazuo Umezawa

1

1 reference

PubMed ID

12804696

6 August 2017

Mariko Kawakami

series ordinal

2

1 reference

PubMed ID

12804696

6 August 2017

Takumi Watanabe

series ordinal

3

1 reference

6 August 2017

1 July 2003

1 reference

Pharmacology & Therapeutics

6 August 2017

1 reference

6 August 2017

99

1 reference

6 August 2017

1

1 reference

6 August 2017

15-24

1 reference

Pulchellalactam: a CD45 protein tyrosine phosphatase inhibitor from the marine fungus Corollospora pulchella.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

CAP defines a second signalling pathway required for insulin-stimulated glucose transport

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2Pmp

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

STI571 (Gleevec) as a paradigm for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Enhancement or induction of neurite formation by a protein tyrosine phosphatase inhibitor, 3,4-dephostatin, in growth factor-treated PC12h cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Thiophosphorylated substrate analogs are potent active site-directed inhibitors of protein-tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Antidiabetic effect of a nitrosamine-free dephostatin analogue, methoxime-3,4-dephostatin, in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Transforming gene product of Rous sarcoma virus phosphorylates tyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy,isolation, and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Phosphatoquinones A and B, novel tyrosine phosphatase inhibitors produced by Streptomyces sp.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. II. Structure determination

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Aporphine alkaloids, CD45 protein tyrosine phosphatase inhibitors, from Rollinia ulei

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Antineoplastic effect of erbstatin on human mammary and esophageal tumors in athymic nude mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Thymine-methyl/pi interaction implicated in the sequence-dependent deformability of DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

Synthesis and protein tyrosine phosphatase inhibitory activity of dephostatin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900050-0

7 January 2021

10.1016/S0163-7258(03)00050-0

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12804696